D&O Ongoing Disclosure for Chris Fleury

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To NZX Limited; and
Name of listed issuer:
Comvita Limited
Date this disclosure made:
9-Jan-19
Date of last disclosure:
23-Nov-18
Director or senior manager giving disclosure
Full name(s):
Christine Mary Fleury
Name of listed issuer:
Comvita Limited
Name of related body corporate (if applicable):
n/a
Position held in listed issuer:
Board Secretary
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Class of affected quoted financial products:
Ordinary Shares
Nature of the affected relevant interest(s):Craigs Start Scheme A/C - registered holder
For that relevant interest-
Number held in class before acquisition or disposal:Craigs Start Scheme A/C - 1,989
Tutamai Trust - 110,000
Number held in class after acquisition or disposal:Craigs Start Scheme A/C - 2,416
Tutamai Trust - 110,000
Current registered holder(s):
Christine Mary Fleury
Registered holder(s) once transfers are registered:
Christine Mary Fleury
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:
2
Details of transactions requiring disclosure-
Date of transaction:
Various
Nature of transaction: 08 Jan 2019 - 441 ordinary shares acquired
pursuant to a non-discretionary fixed trading
plan, to which shares will be acquired on a
monthly basis without interruption over the next
12 months. This is the seventh acquisition of
shares pursuant to the fixed trading plan.
Sale of 14 ordinary shares for management
fees.
Name of any other party or parties to the transaction (if known):n/a
The consideration, expressed in New Zealand dollars, paid or received for the acquisition
or disposal. If the consideration was not in cash and cannot be readily by converted into a
cash value, describe the consideration:
$2,001.64 fixed trading plan
$81.86 - sale of shares
Number of financial products to which the transaction related: 1
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:No
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
n/a
Date of the prior written clearance (if any):
n/a
Certification
I certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all persons for
whom it is made.
Signature of director or officer:
Date of signature:
9-Jan-19